Please note our Product Finder does not contain our complete product portfolio. Should you wish for further information on a specific product, please contact us.
Contact customer care

Press center

Results from 1 to 5 on 24
Refine your search :
Roquette Expands Global Reach of Plant-Based Excipients Portfolio with Complete Acquisition of Crest Cellulose
Following its purchase of a majority share in the company in 2018, this latest move allows Roquette to continue realizing its strong growth ambitions and meet rising global demand for high-quality plant-based excipients.
Roquette expands PEARLITOL® SD mannitol range for highly sensitive active pharmaceutical ingredients (APIs)
Developed specifically for active pharmaceutical ingredients (APIs) that are highly sensitive to reducing sugars, PEARLITOL® 150 SD supports opportunities to unlock advanced tablet dosage forms – even when using challenging active ingredients.
€25 million Investment for Polyols at Lestrem site, France
Roquette invests €25 million at its site in Lestrem, France, to strengthen its unique position in the polyols market.
Cell therapy acceleration strategy - OPTI-STEM project
"Biotherapies and Bioproduction of Innovative Therapies" acceleration strategy: the R&D consortium led by Cell-Easy obtained public funding. Read more...
Roquette Reveals New US-Based Pharmaceutical Innovation Center
The group accelerates its pharmaceutical business expansion in the Americas to consolidate its global leadership position and reinforce its commitment to customer-focused innovation.